Medication Details
- Brand
Cellen™ Therapeutics- Designation
- T200
- Chemotype
- Type I: High THC
- Carrier Oil
- Medium-Chain Triglycerides
- THC Potential Range (±10%)
- 180-220mg/ml
- CBD Potential Range (±10%)
- 0.18-0.22mg/ml
- Distributor
- Curaleaf® Laboratories
- Cultivated/Produced in
Netherlands- Imported by
- Curaleaf® Laboratories
- Imported as
- Schedule I: Raw Material
- Formulated in
- United Kingdom
- Formulated by
- Curaleaf® Laboratories
Stock Availability
We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.
Best-Known Status: Discontinued
We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.
*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.
Formulated using MCT as a carrier oil, all Cellen oils are formulated using Bedrocan® cultivated and manufactured extracts.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
Further National Health-Service Information on